The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Delayed onset drug-induced acute liver failure associated with Glatiramer acetate use in multiple sclerosis requiring liver transplantation
Abstract
Glatiramer acetate (GA) has been used for the treatment of relapsing multiple sclerosis (MS) since 1996. We describe a 59-year-old woman with well-controlled MS on long-term GA who presented with three weeks of jaundice and dark-colored urine and elevated liver enzymes and had biopsy-proven drug induced liver injury. The patient underwent expedited liver transplant evaluation and successfully underwent deceased donor liver transplant. Our case illustrates the first case of acute liver failure (ALF) associated with Glatiramer acetate use requiring liver transplantation. Patients on GA should have long term regular liver monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most commonly implicated medications for idiosyncratic DILI are antimicrobials, immunomodulatory agents, and central nervous system agents.[2,10,12,13]”
From Drug-induced liver injury: Diagnosis, management and the role of liver transplantation (2025) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Research works printed but not linked: 5
- Biolato, 2021, The disease-modifying therapies of relapsing-remitting multiple sclerosis and liver injury: a narrative review, CNS Drugs, 35, 861, 10.1007/s40263-021-00842-9 · DOI
- Onmez, 2013, Drug-induced liver injury by glatiramer acetate used for treatment of multiple sclerosis: a case report, J Investig Med High Impact Case Rep, 1
- Deltenre, 2009, Acute hepatitis induced by glatiramer acetate, BMJ Case Rep, 2009, 10.1136/bcr.09.2008.0913 · DOI
- Subramaniam, 2012, Glatiramer acetate induced hepatotoxicity, Curr Drug Saf, 7, 186, 10.2174/157488612802715690 · doi:10.2174/157488612802715690
- Sanabria-Cabrera, 2022, N-Acetylcysteine for the management of non-acetaminophen drug-induced liver injury in adults: a systematic review, Front Pharmacol, 13, 10.3389/fphar.2022.876868 · DOI · Paper page
Cited by
Drug-induced liver injury: Diagnosis, management and the role of liver transplantation
Ozturk, N. B., Uskudar, E., Toruner, M. D., Simsek, C., & Gurakar, A. (2025) · Hepatology Forum · doi:10.14744/hf.2024.2024.0003 · Cited by 9
Self-citation
Metadata
- Authors
- Edwards, D., Lin, C., Lin, J., Oshima, K., King, E. A., Wesson, R. N., & Gurakar, A.
- Venue
- Journal of Liver Transplantation
- Publisher
- Elsevier BV
- Published
- 2024-02
- Volume
- 13
- Pages
- 100201
- ISSN
- 2666-9676
- Cited by
- 1
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.